Welcure Drugs & Pharmaceuticals has informed that the meeting of the Board of Directors of the Company is scheduled on 11/01/2020, to consider and approve the Unaudited Financial Results of the Company for the Quarter and Nine months ended December 31, 2019.
The above information is a part of company’s filings submitted to BSE.